These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1438 related articles for article (PubMed ID: 33742096)

  • 21. Altered Respiratory Microbiomes, Plasma Metabolites, and Immune Responses in Influenza A Virus and Methicillin-Resistant Staphylococcus aureus Coinfection.
    Chen Q; Liu M; Guo H; Wang K; Liu J; Wang Y; Lin Y; Li J; Li P; Yang L; Jia L; Yang J; Li P; Song H
    Microbiol Spectr; 2023 Aug; 11(4):e0524722. PubMed ID: 37318361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
    Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
    Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Upper Respiratory Tract Microbiome Network Impacted by SARS-CoV-2.
    Li W; Ma ZS
    Microb Ecol; 2023 Aug; 86(2):1428-1437. PubMed ID: 36509943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
    Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
    Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unraveling the Interconnection Patterns Across Lung Microbiome, Respiratory Diseases, and COVID-19.
    Stavropoulou E; Kantartzi K; Tsigalou C; Konstantinidis T; Voidarou C; Konstantinidis T; Bezirtzoglou E
    Front Cell Infect Microbiol; 2020; 10():619075. PubMed ID: 33585285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition.
    Braun T; Halevi S; Hadar R; Efroni G; Glick Saar E; Keller N; Amir A; Amit S; Haberman Y
    Sci Rep; 2021 Apr; 11(1):8922. PubMed ID: 33903709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
    Wang M; Zhang Y; Li C; Chang W; Zhang L
    Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metatranscriptome of human lung microbial communities in a cohort of mechanically ventilated COVID-19 Omicron patients.
    Wang L; Cao JB; Xia BB; Li YJ; Zhang X; Mo GX; Wang RJ; Guo SQ; Zhang YQ; Xiao K; Zhu GF; Liu PF; Song LC; Ma XH; Xiang PC; Wang J; Liu YH; Xie F; Zhang XD; Li XX; Sun WL; Cao Y; Wang KF; Zhang WH; Zhao WC; Yan P; Chen JC; Yang YW; Yu ZK; Tang JS; Xiao L; Zhou JM; Xie LX; Wang J
    Signal Transduct Target Ther; 2023 Nov; 8(1):432. PubMed ID: 37949875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
    Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A
    Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes.
    Hernández-Terán A; Mejía-Nepomuceno F; Herrera MT; Barreto O; García E; Castillejos M; Boukadida C; Matias-Florentino M; Rincón-Rubio A; Avila-Rios S; Mújica-Sánchez M; Serna-Muñoz R; Becerril-Vargas E; Guadarrama-Pérez C; Ahumada-Topete VH; Rodríguez-Llamazares S; Martínez-Orozco JA; Salas-Hernández J; Pérez-Padilla R; Vázquez-Pérez JA
    Sci Rep; 2021 Oct; 11(1):21297. PubMed ID: 34716394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The human microbiome and COVID-19: A systematic review.
    Yamamoto S; Saito M; Tamura A; Prawisuda D; Mizutani T; Yotsuyanagi H
    PLoS One; 2021; 16(6):e0253293. PubMed ID: 34161373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.
    Zhou Z; Ren L; Zhang L; Zhong J; Xiao Y; Jia Z; Guo L; Yang J; Wang C; Jiang S; Yang D; Zhang G; Li H; Chen F; Xu Y; Chen M; Gao Z; Yang J; Dong J; Liu B; Zhang X; Wang W; He K; Jin Q; Li M; Wang J
    Cell Host Microbe; 2020 Jun; 27(6):883-890.e2. PubMed ID: 32407669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extensive microbiological respiratory tract specimen characterization in critically ill COVID-19 patients.
    Thomsen K; Pedersen HP; Iversen S; Wiese L; Fuursted K; Nielsen HV; Christensen JJE; Nielsen XC
    APMIS; 2021 Jul; 129(7):431-437. PubMed ID: 33950572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of Lung and Gut Microbiota in IL-13-Transgenic Mice Simulating Chronic Asthma.
    Sohn KH; Baek MG; Choi SM; Bae B; Kim RY; Kim YC; Kim HY; Yi H; Kang HR
    J Microbiol Biotechnol; 2020 Dec; 30(12):1819-1826. PubMed ID: 33046682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host.
    Lloréns-Rico V; Gregory AC; Van Weyenbergh J; Jansen S; Van Buyten T; Qian J; Braz M; Menezes SM; Van Mol P; Vanderbeke L; Dooms C; Gunst J; Hermans G; Meersseman P; ; Wauters E; Neyts J; Lambrechts D; Wauters J; Raes J
    Nat Commun; 2021 Oct; 12(1):6243. PubMed ID: 34716338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metatranscriptomic analysis revealed
    Lu S; Zhou Y; Hu Y; Wang J; Li H; Lin Y; Wang D; Xian J; Zhao S; Ma J; Zhu Z; Yang S; Meng Q; Kang Y; Chen B; Li W
    Front Cell Infect Microbiol; 2023; 13():1161763. PubMed ID: 37333851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome.
    Shilts MH; Rosas-Salazar C; Strickland BA; Kimura KS; Asad M; Sehanobish E; Freeman MH; Wessinger BC; Gupta V; Brown HM; Boone HH; Patel V; Barbi M; Bottalico D; O'Neill M; Akbar N; Rajagopala SV; Mallal S; Phillips E; Turner JH; Jerschow E; Das SR
    Front Cell Infect Microbiol; 2021; 11():781968. PubMed ID: 35141167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.
    Sokol H; Contreras V; Maisonnasse P; Desmons A; Delache B; Sencio V; Machelart A; Brisebarre A; Humbert L; Deryuter L; Gauliard E; Heumel S; Rainteau D; Dereuddre-Bosquet N; Menu E; Ho Tsong Fang R; Lamaziere A; Brot L; Wahl C; Oeuvray C; Rolhion N; Van Der Werf S; Ferreira S; Le Grand R; Trottein F
    Gut Microbes; 2021; 13(1):1-19. PubMed ID: 33685349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysbiosis of oropharyngeal microbiome and antibiotic resistance in hospitalized COVID-19 patients.
    Wu J; Liu W; Zhu L; Li N; Luo G; Gu M; Peng M; Zeng S; Wu S; Zhang S; Chen Q; Cai M; Cao W; Jiang Y; Luo C; Tian D; Shi M; Shu Y; Chang G; Luo H
    J Med Virol; 2023 Apr; 95(4):e28727. PubMed ID: 37185870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiota as a potentially-modifiable factor influencing COVID-19.
    Ngo VL; Gewirtz AT
    Curr Opin Virol; 2021 Aug; 49():21-26. PubMed ID: 34000641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.